Author:
Nguyen Alexander T.,Elia Maxwell,Materin Miguel A.,Sznol Mario,Chow Jessica
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference6 articles.
1. . Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.;Brahmer;N Engl J Med,2012
2. . Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (Checkmate 063): a phase 2, single-arm trial.;Rizvi;Lancet Oncol,2015
3. . Nivolumab plus ipilimumab in advanced melanoma.;Wolchok;N Engl J Med,2013
4. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.;Roberts;Cornea,2007
5. Life span of naive and memory T cells.;Tough;Stem Cells,1995
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献